Sugar-sweetened beverage taxes emerging evidence on a new public health policy
Madsen KA, Krieger J, Morales X
JAMA. 2019;321(18):1777-9
Leggi
Breaking news
Digital health technology and mobile devices for the management of diabetes mellitus: state of the art
Shan R, Sarkar S, Martin SS
Diabetologia. 2019;62:877-7
Leggi
Gestational diabetes and the risk of cardiovascular disease in women: a systematic review and meta-analysis
Kramer CK, Campbell S, Retnakaran R
Diabetologia. 2019;62:905-14
Leggi
Moderate weight change following diabetes diagnosis and 10 year incidence of cardiovascular disease and mortality
Strelitz J, Ahern AL, Long GH, et al.
Diabetologia. Published online 7 May 2019
Leggi
Efficacy and safety of evolocumab in individuals with type 2 diabetes mellitus: primary results of the randomised controlled BANTING study
Rosenson RS, Daviglus ML, Handelsman Y, et al.
Diabetologia. 2019;62:948-58
Leggi
Effects of canagliflozin on amputation risk in type 2 diabetes: the CANVAS Program
Matthews DR, Li Q, Perkovic V, et al.
Diabetologia. 2019;62:926-38
Leggi
Liraglutide in children and adolescents with type 2 diabetes
Tamborlane WV, Barrientos-Pérez M, Fainberg U, et al.
N Engl J Med. Pub. online 28 Apr 2019
Leggi
Physical inactivity, cardiometabolic disease, and risk of dementia: an individual-participant meta-analysis
Kivimäki M, Singh-Manoux A, Pentti J, et al.
BMJ. 2019;365:l1495
Leggi
Glucose screening in pregnancy and future risk of cardiovascular disease in women: a retrospective, population-based cohort study
Retnakaran R, Shah BR
Lancet Diabetes Endocrinol. 2019;7(5):378-84
Leggi
Clinical practice recommendations on the routine use of eversense, the first long-term implantable continuous glucose monitoring system
Deiss D, Szadkowska A, Gordon D, et al.
Diabetes Technology & Therapeutics. Pub. Online 25 Apr 2019
Leggi